Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract Aims Current hypertension guidelines focus on blood pressure control, but incorporating end-organ imaging could improve understanding of disease manifestations. We undertook a systematic review to evaluate current task-level applications of artificial intelligence (AI) and computational approaches to imaging for hypertension identification, phenotyping, and outcome prediction. Methods and Results A systematic search was conducted across multiple databases up to end of December 2025. Retrieved studies were grouped by AI task, and a thematic qualitative analysis per-task was conducted to evaluate organ-specific findings, AI methodologies, and research gaps. For quantitative synthesis, the I2 statistic derived from Cochran’s Q test was used to assess heterogeneity, and forest plots were generated to visualise effect sizes. The review was registered with PROSPERO (CRD42023427430). The search strategy yielded 48 studies. Thematic analysis categorised the studies into five major tasks, with the majority employing supervised learning for classification processes. Nearly half of the studies focused on the heart. However, paucity of studies performed multi-organ assessment, external validation, and phenotyping or predicting future risk. AI and computational approaches in imaging achieved an overall sensitivity of 0.84 [0.69—0.93] in identifying hypertension from normotension, highest with brain imaging. Sensitivity reached 0.92 [0.90—0.94] in discriminating hypertension from hypertrophic cardiomyopathy. Conclusion Current research focusses primarily on hypertension prediction using single organ information. While results are promising, datasets remain small with limited external validation. There remains a need for discovery-oriented research to uncover disease heterogeneity, multi-organ phenotypes, and support personalised and targeted interventions.

More information Original publication

DOI

10.1093/ehjdh/ztag063

Type

Journal article

Publisher

Oxford University Press (OUP)

Publication Date

2026-04-20T00:00:00+00:00